Douglas Plassche

CIK: 0001600946

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELTP

ELITE PHARMACEUTICALS INC /NV/

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ELTP
ELITE PHARMACEUTICALS INC /NV/
Jan 9, 2026
Exercise(M)
Direct
2.5M shares at avg. $0.03$75K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Oct 2, 2025
Sale(S)
Direct
800K shares at avg. $0.62$499K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Jul 8, 2025
Sale(S)
Direct
200K shares at avg. $0.58$116K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Jul 3, 2025
Exercise(M)
Direct
2.5M shares at avg. $0.03$75K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Oct 24, 2024
Sale(S)
Direct
333.9K shares at avg. $0.51$170K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Oct 23, 2024
Sale(S)
Direct
800K shares at avg. $0.49$392K

		Type	Shares	Price		Ownership
Jan 9, 2026	ELTP ELITE PHARMACEUTICALS INC /NV/	Exercise(M)	2,500,000	$0.03	$75,000	Direct
Oct 2, 2025	ELTP ELITE PHARMACEUTICALS INC /NV/	Sale(S)	800,000	$0.62	$499,200	Direct
Jul 8, 2025	ELTP ELITE PHARMACEUTICALS INC /NV/	Sale(S)	200,000	$0.58	$115,800	Direct
Jul 3, 2025	ELTP ELITE PHARMACEUTICALS INC /NV/	Exercise(M)	2,500,000	$0.03	$75,000	Direct
Oct 24, 2024	ELTP ELITE PHARMACEUTICALS INC /NV/	Sale(S)	333,932	$0.51	$170,305	Direct
Oct 23, 2024	ELTP ELITE PHARMACEUTICALS INC /NV/	Sale(S)	800,000	$0.49	$392,000	Direct

1-6 of 6 transactions

About Plassche Douglas

Plassche Douglas (SEC CIK 0001600946) files insider reports with the SEC as EVP Operations of ELITE PHARMACEUTICALS INC /NV/ (ELTP).

Signal8 holds 5 ownership filings by Plassche Douglas, all Form 4s, filed between Oct 28, 2024 and Jan 13, 2026. Those filings report 6 transactions, from Oct 23, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Plassche Douglas's filings is in NORTHVALE, NJ.

Recent filings by Plassche Douglas

Jan 9, 2026: Option exercise of ELTP shares (Form 4, code M).
Oct 2, 2025: Open-market sale of ELTP shares (Form 4, code S).
Jul 8, 2025: Open-market sale of ELTP shares (Form 4, code S).
Jul 3, 2025: Option exercise of ELTP shares (Form 4, code M).
Oct 24, 2024: Open-market sale of ELTP shares (Form 4, code S).

Other insiders filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP)

Dash Barry H, Director
ELITE PHARMACEUTICALS INC /NV/, EVP Operations
Kirkov Kirko, Chief Commercial Officer

How to read Form 4 transaction codes